Transforming growth factor ,B1 (TGF ,B1) is a preoperative prognostic indicator in advanced gastric carcinoma
1998

TGF-B1 as a Prognostic Indicator in Advanced Gastric Cancer

Sample size: 42 publication Evidence: high

Author Information

Author(s): M Nakamura, M Katano, A Kuwahara, K Fujimoto, K Miyazaki, T Morisaki, M Mori

Primary Institution: Saga Medical School

Hypothesis

TGF-B1 expression at the site of carcinoma may contribute to highly malignant behavior in advanced gastric tumors.

Conclusion

TGF-B1 mRNA expression in gastric biopsy specimens is a significant preoperative prognostic indicator for advanced gastric carcinoma.

Supporting Evidence

  • TGF-B1-positive patients had a shorter overall survival compared to TGF-B1-negative patients.
  • Significant correlations were found between TGF-B1 mRNA expression and tumor stage.
  • TGF-B1 mRNA expression was identified as an independent prognostic factor.

Takeaway

This study found that a specific protein, TGF-B1, in stomach cancer samples can help doctors predict how aggressive the cancer is.

Methodology

The study used reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze TGF-B1 mRNA in biopsy specimens from patients with advanced gastric carcinoma.

Limitations

The study excluded early-stage patients and focused only on advanced cases.

Participant Demographics

The study involved 42 patients with advanced gastric carcinoma, with a follow-up duration ranging from 4 to 37 months.

Statistical Information

P-Value

0.0014

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication